NS
Narsin Surender
About Narsin Surender
Data last updated:
Narsin Surender is a Director at Stride Organics Private Limited (since 2009), Director at Unifranco Life Sciences Pvt Ltd (since 2006) and Director at Stride Formulations Private Limited (since 2010). The companies operate in Chemicals and Materials and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹80.12 Cr; the largest is Stride Organics Private Limited at ₹72.83 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Stride Organics Private Limited U24239TG2005PTC046195 | Director | 22 Jan 2009 | 2005 | ₹72.83 Cr (FY 2023) | Active |
 Unifranco Life Sciences Pvt Ltd U24239TG2006PTC049181 | Director | 16 Feb 2006 | 2006 | ₹7.29 Cr (FY 2023) | Active |
| Stride Formulations Private Limited U24232TG2010PTC070897 | Director | 20 Oct 2010 | 2010 | Active |
Board colleagues of Narsin Surender
| Name | DIN | Company | Designation |
|---|---|---|---|
| Narsin Akash | 09595814 | Stride Organics Private Limited , Unifranco Life Sciences Pvt Ltd | Director |
| Hanumanth Rao Gangavelli | 00037326 | Stride Formulations Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narsin Surender
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narsin Surender
Narsin Surender currently holds 3 directorships: Stride Organics Private Limited (Director, since 22 Jan 2009, revenue ₹72.83 Cr (FY 2023)); Unifranco Life Sciences Pvt Ltd (Director, since 16 Feb 2006, revenue ₹7.29 Cr (FY 2023)); Stride Formulations Private Limited (Director, since 20 Oct 2010).
Narsin Surender was first appointed on 16 Feb 2006 as Director at Unifranco Life Sciences Pvt Ltd. The most recent appointment on record is 20 Oct 2010 at Stride Formulations Private Limited.
The 2 current companies of Narsin Surender that report revenue have a combined latest revenue of ₹80.12 Cr: Stride Organics Private Limited ₹72.83 Cr (FY 2023); Unifranco Life Sciences Pvt Ltd ₹7.29 Cr (FY 2023).
The current boards of Narsin Surender's companies include Narsin Akash (Stride Organics Private Limited), Hanumanth Rao Gangavelli (Stride Formulations Private Limited).